You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 7, 2025

Drug Price Trends for NDC 49348-0305


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 49348-0305

Drug Name NDC Price/Unit ($) Unit Date
SM MILK OF MAGNESIA SUSPENSION 49348-0305-39 0.00960 ML 2025-01-22
SM MILK OF MAGNESIA SUSPENSION 49348-0305-39 0.00968 ML 2024-12-18
SM MILK OF MAGNESIA SUSPENSION 49348-0305-39 0.00949 ML 2024-11-20
SM MILK OF MAGNESIA SUSPENSION 49348-0305-39 0.00986 ML 2024-10-23
SM MILK OF MAGNESIA SUSPENSION 49348-0305-39 0.00997 ML 2024-09-18
SM MILK OF MAGNESIA SUSPENSION 49348-0305-39 0.00952 ML 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 49348-0305

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for the Drug NDC: 49348-0305

Introduction

When analyzing the market and projecting prices for a specific drug, several factors come into play, including regulatory approvals, market trends, and economic forecasts. Here, we will delve into the key aspects that influence the pricing and market dynamics of the drug identified by the NDC 49348-0305.

Understanding NDCs

The National Drug Code (NDC) is a unique identifier assigned to each drug product, including the labeler, product, and packaging. The NDC 49348-0305 would be associated with a specific drug product, its manufacturer, and packaging details[1].

Regulatory Environment

The regulatory environment plays a crucial role in determining the market viability and pricing of a drug. Drugs must have approved New Drug Applications (NDAs) to be marketed and included in rebate programs. Any changes in FDA approvals or enforcement actions can significantly impact the drug's market presence and pricing[5].

Current Market Trends

The pharmaceutical industry is experiencing several transformative trends that affect drug pricing:

Drug Price Inflation

According to Vizient's summer 2024 Pharmacy Market Outlook, the overall drug price inflation rate for pharmaceuticals in 2025 is projected to be 3.81%. This inflation is driven by factors such as expanding indications for previously approved medications and the introduction of high-cost cell and gene therapies[2].

Expanding Indications

Medications like semaglutide, which have seen a 77% increase in spend due to new indications, are a significant factor in current market trends. These expanded uses can lead to higher demand and potentially higher prices[2].

High-Cost Therapies

The introduction of high-cost therapies, such as chimeric antigen receptor T-cell (CAR-T) therapies, is also impacting the market. These therapies, priced at over $455,000 per treatment, are becoming more prevalent and will significantly affect provider budgets and operational processes[2].

Personalization and Prevention

The pharmaceutical industry is shifting towards more personalized and preventive care. This includes data-driven, customized treatments and a focus on addressing risk factors for health decline. While this trend is more about the direction of the industry rather than immediate price impacts, it could influence long-term pricing strategies as healthcare becomes more tailored and preventive[3].

Policy and Economic Factors

Policy changes and economic conditions also influence drug pricing. For instance, changes in administration and policy can impact health policies, tariffs, taxes, and M&A oversight, all of which can accelerate changes in the pharmaceutical market[3].

Historical Price Fluctuations

Historical data shows that drug prices can fluctuate, but these changes are often minimal and infrequent. For example, a study by the Office of Inspector General (OIG) found that only about 1% of drug prices changed in most weeks, with a median increase of approximately 7% in any given week[4].

Price Projections for NDC 49348-0305

Given the current market trends and projections:

  • Inflation Impact: The drug price inflation rate of 3.81% projected for 2025 could apply to the NDC 49348-0305, assuming it is not exempt from general market trends.
  • Regulatory Stability: If the drug has an approved NDA and is not subject to any enforcement actions, its market presence and pricing would be more stable.
  • Market Demand: If the drug has expanding indications or is part of a therapeutic class seeing increased demand (like GLP-1 agents), this could drive up prices.
  • Economic and Policy Factors: Any significant policy changes or economic shifts could impact the pricing strategy for this drug.

Key Takeaways

  • The pharmaceutical market is experiencing a 3.81% price inflation rate in 2025.
  • Expanding indications and high-cost therapies are significant drivers of price increases.
  • Regulatory approvals and stability are crucial for maintaining market presence.
  • Personalized and preventive care trends may influence long-term pricing strategies.
  • Historical data shows that drug price changes are often minimal and infrequent.

FAQs

Q: What is the projected drug price inflation rate for 2025? A: The projected drug price inflation rate for 2025 is 3.81% according to Vizient's summer 2024 Pharmacy Market Outlook[2].

Q: How do expanding indications affect drug prices? A: Expanding indications can increase demand and drive up prices, as seen with medications like semaglutide, which experienced a 77% increase in spend[2].

Q: What impact do high-cost therapies have on the market? A: High-cost therapies, such as CAR-T therapies, significantly impact provider budgets and operational processes, and are priced at over $455,000 per treatment[2].

Q: How do regulatory changes affect drug pricing? A: Regulatory changes, such as FDA approvals or enforcement actions, can significantly impact the market presence and pricing of a drug. Unapproved drugs cannot be marketed without appropriate FDA approval[5].

Q: What are the long-term trends shaping the pharmaceutical industry? A: The industry is moving towards prevention, personalization, prediction, and more accessible care settings. These trends are expected to shape the future of pharmaceuticals[3].

Sources

  1. CDC - IIS | Code Sets | NDC | Vaccines | CDC
  2. Vizient - Vizient projects drug price inflation at 3.81%
  3. PwC - Pharma industry trends: PwC
  4. OIG - Temporary Medicare-Approved Drug Discount Card: An Analysis of Drug Prices
  5. Medicaid.gov - For State Medicaid Directors - NEW DRUG DETERMINATIONS--DELETIONS FROM MDR

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.